According to this study simultaneously presented at the European Society of Cardiology Congress 2017 and published in the New England Journal of Medicine, routinely providing supplemental oxygen therapy to patients without hypoxemia with suspected acute myocardial infarction did not result in a reduction in the 1-year risk of all-cause mortality when compared with patients receiving<a href="https://solaci.org/en/2017/09/13/deto2x-ami-supplemental-o2-provides-no-benefit-for-patients-with-suspected-infarction/" title="Read more" >...</a>
